Old Web
One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes
2016
Diabetes & Metabolism - In Press.Proof corrected by the author Available online since mercredi 28 septembre 2016
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI